Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 12, 2023
Total Value: $128M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 728,585 | $50.5M | 39.5% | $69.31 * | $44.70 | +37.6% | COM | 110122108 |
| — | BIODESIX INC | 5,039,633 | $9.374M | 7.3% | $1.86 | $6.11 | — | COM | 09075X108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 84,240 | $8.527M | 6.7% | $101.22 * | $72.40 | +43.7% | COM | 64125C109 |
| PRTA | PROTHENA CORP PLC | 128,395 | $6.223M | 4.9% | $48.47 * | $34.60 | +52.7% | SHS | G72800108 |
| — | QUIDELORTHO CORP | 61,306 | $5.462M | 4.3% | $89.09 | $68.13 | — | COM | 74838J101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 249,400 | $4.694M | 3.7% | $18.82 | $35.16 | -45.8% | COM | 004225108 |
| HROW | HARROW HEALTH INC | 180,000 | $3.809M | 3.0% | $21.16 * | $6.05 | +182.1% | COM | 415858109 |
| UTHR | UNITED THERAPEUTICS CORP | 15,000 | $3.359M | 2.6% | $223.93 * | $93.09 | +164.8% | COM | 91307C102 |
| OVV | OVINTIV INC | 84,200 | $3.038M | 2.4% | $36.08 * | $33.44 | +31.9% | COM | 69047Q102 |
| MASI | MASIMO CORP | 15,280 | $2.82M | 2.2% | $184.55 * | $81.54 | +106.9% | COM | 574795100 |
| PHR | PHREESIA INC | 82,700 | $2.67M | 2.1% | $32.29 * | $23.06 | +52.6% | COM | 71944F106 |
| ELUT | AZIYO BIOLOGICS INC | 1,655,184 | $2.499M | 2.0% | $1.51 * | $5.84 | -34.4% | COM | 05479K106 |
| FHTX | FOGHORN THERAPEUTICS INC | 264,843 | $1.642M | 1.3% | $6.20 * | $19.16 | -65.8% | COM | 344174107 |
| — | ACCELERATE DIAGNOSTICS INC | 2,252,388 | $1.577M | 1.2% | $0.70 | $19.28 | — | COM | 00430H102 |
| ALKS | ALKERMES PLC | 50,000 | $1.41M | 1.1% | $28.20 * | $21.00 | +29.7% | SHS | G01767105 |
| — | INHIBRX INC | 70,448 | $1.329M | 1.0% | $18.86 | $31.33 | — | COM | 45720L107 |
| ATEC | ALPHATEC HOLDINGS INC | 80,000 | $1.248M | 1.0% | $15.60 * | $9.84 | +43.7% | COM | 02081G201 |
| — | KARYOPHARM THERAPEUTICS INC | 291,332 | $1.133M | 0.9% | $3.89 | $13.75 | — | COM | 48576U106 |
| CORT | CORCEPT THERAPEUTICS INC | 50,000 | $1.083M | 0.8% | $21.66 | $6.85 | +219.9% | COM | 218352102 |
| DCGO | DOCGO INC | 110,000 | $952K | 0.7% | $8.65 | $7.69 | +14.7% | COM | 256086109 |
| VTYX | VENTYX BIOSCIENCES INC | 26,400 | $884K | 0.7% | $33.48 * | $22.39 | +73.7% | COM | 92332V107 |
| CYTK | CYTOKINETICS INC | 25,000 | $880K | 0.7% | $35.20 * | $27.06 | +50.8% | COM | 23282W605 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 38,000 | $874K | 0.7% | $23.00 * | $38.07 | -55.9% | COM | 74366E102 |
| APLS | APELLIS PHARMACEUTICALS INC | 12,000 | $792K | 0.6% | $66.00 * | $37.18 | +55.2% | COM | 03753U106 |
| — | PIONEER NATURAL RESOURCES CO | 3,800 | $776K | 0.6% | $204.21 | $145.33 | — | COM | 723787107 |
| — | EQUITRANS MIDSTREAM CORPORATIO | 133,050 | $769K | 0.6% | $5.78 | $8.31 | — | COM | 294600101 |
| TVTX | TRAVERE THERAPEUTICS INC | 30,000 | $675K | 0.5% | $22.50 * | $21.26 | 0.0% | COM | 89422G107 |
| — | BLUEBIRD BIO INC | 199,200 | $633K | 0.5% | $3.18 | $23.31 | — | COM | 09609G100 |
| — | 2SEVENTY BIO INC | 59,833 | $610K | 0.5% | $10.20 | $19.43 | — | COM | 901384107 |
| — | IVERIC BIO INC | 25,000 | $608K | 0.5% | $24.32 | $16.94 | — | COM | 46583P102 |
| — | IMMUNOGEN INC | 150,000 | $576K | 0.5% | $3.84 | $2.74 | — | COM | 45253H101 |
| TXG | 10X GENOMICS INC | 10,000 | $558K | 0.4% | $55.80 * | $32.70 | +42.8% | CL A COM | 88025U109 |
| — | SOLENO THERAPEUTICS INC | 245,127 | $525K | 0.4% | $2.14 | $0.69 | — | COM | 834203101 |
| ARVN | ARVINAS INC | 15,000 | $410K | 0.3% | $27.33 * | $16.46 | +91.9% | COM | 04335A105 |
| — | SILK ROAD MEDICAL INC | 10,000 | $391K | 0.3% | $39.10 | $42.36 | — | COM | 82710M100 |
| HALO | HALOZYME THERAPEUTICS INC | 10,000 | $382K | 0.3% | $38.20 * | $51.20 | -8.4% | COM | 40637H109 |
| XENE | XENON PHARMACEUTICALS INC | 10,000 | $358K | 0.3% | $35.80 * | $30.24 | +22.1% | COM | 98420N105 |
| — | CHINOOK THERAPEUTICS INC | 15,000 | $347K | 0.3% | $23.13 | $23.13 | — | COM | 16961L106 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,500 | $345K | 0.3% | $138.00 * | $100.79 | +28.7% | COM | 803607100 |
| XNCR | XENCOR INC | 12,300 | $343K | 0.3% | $27.89 * | $15.78 | +95.3% | COM | 98401F105 |
| — | KINIKSA PHARMACEUTICALS LTD | 30,000 | $323K | 0.3% | $10.77 | $13.10 | — | COM | G5269C101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 40,000 | $314K | 0.2% | $7.85 * | $18.69 | -60.1% | COM | 483497103 |
| FOLD | AMICUS THERAPEUTICS INC | 28,000 | $311K | 0.2% | $11.11 * | $14.56 | -15.4% | COM | 03152W109 |
| KROS | KEROS THERAPEUTICS INC | 7,000 | $299K | 0.2% | $42.71 * | $46.71 | +8.1% | COM | 492327101 |
| PGNY | PROGYNY INC | 9,000 | $289K | 0.2% | $32.11 * | $33.03 | 0.0% | COM | 74340E103 |
| CGEM | CULLINAN ONCOLOGY INC | 25,114 | $257K | 0.2% | $10.23 * | $40.60 | -72.8% | COM | 230031106 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 20,000 | $167K | 0.1% | $8.35 * | $6.02 | +60.0% | COM | 09058V103 |
| IFRX | INFLARX NV | 70,000 | $136K | 0.1% | $1.94 * | $3.70 | -41.7% | COM | N44821101 |
| STOK | STOKE THERAPEUTICS INC | 15,000 | $125K | 0.1% | $8.33 * | $24.71 | -63.5% | COM | 86150R107 |
| GOSS | GOSSAMER BIO INC | 99,088 | $125K | 0.1% | $1.26 * | $10.02 | -80.9% | COM | 38341P102 |
| — | G1 THERAPEUTICS INC | 40,000 | $107K | 0.1% | $2.67 | $33.05 | — | COM | 3621LQ109 |
| — | NEKTAR THERAPEUTICS | 118,000 | $83,000 | 0.1% | $0.70 | $15.38 | — | COM | 640268108 |
| — | YIELD10 BIOSCIENCE INC | 18,750 | $52,000 | 0.0% | $2.77 | $6.02 | — | COM | 98585K102 |
| — | ANGION BIOMEDICA CORP | 54,392 | $32,000 | 0.0% | $0.59 | $18.06 | — | COM | 03476J107 |
| — | ASPIRA WOMEN'S HEALTH INC | 60,070 | $22,000 | 0.0% | $0.37 | $3.84 | — | COM | 04537Y109 |